Free Trial

Rep. Tim Moore Purchases Shares of UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Key Points

  • Representative Tim Moore of North Carolina disclosed the purchase of UnitedHealth Group (NYSE:UNH) shares, acquiring between $1,001 and $15,000 on July 21st.
  • UnitedHealth Group's stock recently opened at $245.59, with a market cap of $222.78 billion and a P/E ratio of 10.64, while reporting $4.08 EPS for the last quarter, missing estimates.
  • The company announced a quarterly dividend increase to $2.21, representing an annualized payout of $8.84 and a dividend yield of 3.6%.
  • Need Better Tools to Track UnitedHealth Group? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Representative Tim Moore (R-North Carolina) recently bought shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on August 05th, the Representative disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on July 21st.

Representative Tim Moore also recently made the following trade(s):

  • Purchased $15,001 - $50,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/30/2025.
  • Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/30/2025.
  • Purchased $15,001 - $50,000 in shares of Harley-Davidson NYSE: HOG on 7/30/2025.
  • Purchased $15,001 - $50,000 in shares of Verizon Communications NYSE: VZ on 7/29/2025.
  • Purchased $15,001 - $50,000 in shares of Intel NASDAQ: INTC on 7/29/2025.
  • Purchased $1,001 - $15,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/29/2025.
  • Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/29/2025.
  • Purchased $1,001 - $15,000 in shares of Centene NYSE: CNC on 7/22/2025.
  • Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/21/2025.
  • Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/18/2025.

UnitedHealth Group Trading Down 0.6%

NYSE:UNH traded down $1.37 during mid-day trading on Thursday, reaching $244.42. The company's stock had a trading volume of 11,331,473 shares, compared to its average volume of 18,403,832. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company's fifty day simple moving average is $292.78 and its two-hundred day simple moving average is $408.71. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market cap of $221.72 billion, a P/E ratio of 10.59, a P/E/G ratio of 1.59 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the company posted $6.80 EPS. The business's revenue for the quarter was up 12.9% on a year-over-year basis. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.6%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO John F. Rex purchased 17,175 shares of the stock in a transaction dated Friday, May 16th. The shares were purchased at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the transaction, the chief financial officer owned 203,796 shares in the company, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock worth $31,607,768 over the last 90 days. Corporate insiders own 0.28% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Piper Sandler cut their price objective on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Robert W. Baird reaffirmed an "underperform" rating and set a $198.00 price target (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Royal Bank Of Canada cut their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Erste Group Bank downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Finally, Truist Financial lowered their target price on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research note on Wednesday, July 16th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $366.52.

Read Our Latest Report on UnitedHealth Group

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Citizens National Bank Trust Department lifted its position in shares of UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after buying an additional 170 shares during the last quarter. Fort Washington Investment Advisors Inc. OH boosted its stake in UnitedHealth Group by 0.3% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after acquiring an additional 1,465 shares during the period. Sherbrooke Park Advisers LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $515,000. Full Sail Capital LLC grew its stake in UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock worth $815,000 after buying an additional 33 shares during the last quarter. Finally, Soros Fund Management LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at $39,413,000. Institutional investors own 87.86% of the company's stock.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina's 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Moore (Republican Party) ran for election to the U.S. House to represent North Carolina's 14th Congressional District. He won in the general election on November 5, 2024. Moore served as speaker of the House from 2015 to 2025. Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines